Conditions We Treat

The CRDT offers innovative treatment to treat children who are diagnosed throughout the United States and globally with conditions including:

  • Adrenoleukodystrophy
  • Alpha-1-Antitrypsin (AT) Deficiency
  • Bare Lymphocyte Syndrome (BLS)
  • Byler Disease
  • Chronic Granulomatous Disease (CGD)
  • Chronic Pancreatitis and Acute Recurrent Pancreatitis
  • Combined Immune Deficiency (CID) Syndromes
  • Combined Variable Immune Deficiency(CVID) Syndrome
  • Congenital Corneal Opacity (Peters Anomaly and Sclerocornea)
  • Crigler-Najjar syndrome
  • Fabry Disease
  • Fatty Acid Oxidation Deficiencies
  • Gaucher Disease
  • Glutaric Acidemia Type 1
  • Glycogen Storage Disorders
  • GM3 Synthase Deficiency
  • Hemophagocytic Lymphohistiocytosis (HLH) Syndromes
  • Hereditary Telangiectasia (HHT)
  • Hunter Syndrome (MPS-II)
  • Hurler Syndrome (MPS-I)
  • Krabbe Disease
  • Maple Syrup Urine Disease (MSUD)
  • Metachromatic Leukodystrophy
  • Methylmalonic Acidemia
  • Mitochondrial Disorder
  • Niemann-Pick Disease Type C
  • Phenylketonuria (PKU)
  • Pompe Disease
  • Progressive Familial Intrahepatic Cholestasis
  • Propionic Acidemia
  • Severe Combined Immune Deficiency(SCID)
  • Urea Cycle Disorders
  • Vanishing White Matter Disease